What is the share price of Link Pharmachem Ltd (LINKPH) today?
The share price of LINKPH as on 8th September 2026 is ₹29.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Link Pharmachem Ltd (LINKPH) share?
The past returns of Link Pharmachem Ltd (LINKPH) share are- Past 1 week: 3.41%
- Past 1 month: 9.50%
- Past 3 months: 11.03%
- Past 6 months: 4.71%
- Past 1 year: -16.26%
- Past 3 years: -42.12%
- Past 5 years: -12.48%
What are the peers or stocks similar to Link Pharmachem Ltd (LINKPH)?
The peers or stocks similar to Link Pharmachem Ltd (LINKPH) include:What is the market cap of Link Pharmachem Ltd (LINKPH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Link Pharmachem Ltd (LINKPH) is ₹12.21 Cr as of 8th September 2026.What is the 52 week high and low of Link Pharmachem Ltd (LINKPH) share?
The 52-week high of Link Pharmachem Ltd (LINKPH) is ₹41.90 and the 52-week low is ₹21.What is the PE and PB ratio of Link Pharmachem Ltd (LINKPH) stock?
The P/E (price-to-earnings) ratio of Link Pharmachem Ltd (LINKPH) is 203.53. The P/B (price-to-book) ratio is 0.95.Which sector does Link Pharmachem Ltd (LINKPH) belong to?
Link Pharmachem Ltd (LINKPH) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy Link Pharmachem Ltd (LINKPH) shares?
You can directly buy Link Pharmachem Ltd (LINKPH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Link Pharmachem Ltd
LINKPH Share Price
BSE₹29.4012.64% (+3.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
LINKPH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
LINKPH Performance & Key Metrics
LINKPH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1,221.16 | 0.95 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 24.95 | 3.16 | 1.39% |
LINKPH Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
LINKPH Company Profile
Link Pharma Chem Limited manufactures organic intermediates for pharmaceuticals and specialty chemicals, providing contract manufacturing and synthesis services.
SOLARINDS
PE Ratio
107.34
107.34
1Y Return
59.92%
59.92%
Buy Reco %
78.57
78.57
LINDEINDIA
PE Ratio
103.65
103.65
1Y Return
1.76%
1.76%
Buy Reco %
0.00
0.00
PE Ratio
43.95
43.95
1Y Return
48.26%
48.26%
Buy Reco %
0.00
0.00
SUMICHEM
PE Ratio
49.15
49.15
1Y Return
13.65%
13.65%
Buy Reco %
88.89
88.89
DEEPAKNTR
PE Ratio
43.28
43.28
1Y Return
5.59%
5.59%
Buy Reco %
58.82
58.82
LINKPH Forecast
LINKPH Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
LINKPH
LINKPH
Income
Balance Sheet
Cash Flow
Quarterly Normal View
LINKPH Income Statement
LINKPH Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8.02 | 9.12 | 5.16 | 4.78 | 6.56 | 8.02 | 6.34 | 6.53 | 6.74 | 9.12 | ||||||||||
Operating & Other expenses | 7.11 | 8.30 | 5.10 | 5.23 | 6.67 | 7.17 | 5.95 | 6.04 | 6.83 | 8.31 | ||||||||||
EBITDA | 0.91 | 0.82 | 0.06 | -0.45 | -0.11 | 0.85 | 0.39 | 0.49 | -0.09 | 0.81 | ||||||||||
| Depreciation/Amortization | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.25 | 0.25 | 0.25 | 0.27 | ||||||||||
| PBIT | 0.66 | 0.58 | -0.18 | -0.69 | -0.35 | 0.61 | 0.14 | 0.24 | -0.34 | 0.54 | ||||||||||
| Interest & Other Items | 0.19 | 0.22 | 0.21 | 0.21 | 0.14 | 0.10 | 0.13 | 0.14 | 0.15 | 0.14 | ||||||||||
| PBT | 0.47 | 0.36 | -0.39 | -0.90 | -0.49 | 0.51 | 0.01 | 0.10 | -0.49 | 0.40 | ||||||||||
| Taxes & Other Items | 0.21 | 0.06 | -0.08 | -0.22 | -0.13 | 0.11 | 0.00 | 0.04 | -0.08 | 0.07 | ||||||||||
| Net Income | 0.26 | 0.30 | -0.31 | -0.68 | -0.36 | 0.40 | 0.01 | 0.06 | -0.41 | 0.33 | ||||||||||
| EPS | 0.59 | 0.67 | -0.69 | -1.50 | -0.79 | 0.91 | 0.03 | 0.15 | -0.92 | 0.72 |
LINKPH Company Updates
LINKPH Stock Peers
LINKPH Past Performance & Peer Comparison
LINKPH Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Link Pharmachem Ltd | 203.53 | 0.95 | — |
| Solar Industries India Ltd | 107.34 | 27.50 | 0.06% |
| Linde India Ltd | 103.65 | 13.34 | 0.18% |
| Himadri Speciality Chemical Ltd | 43.95 | 6.93 | 0.12% |
LINKPH Stock Price Comparison
Compare LINKPH with any stock or ETFCompare LINKPH with any stock or ETF
LINKPH
LINKPH Holdings
LINKPH Shareholdings
LINKPH Promoter Holdings Trend
LINKPH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
LINKPH Institutional Holdings Trend
LINKPH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
LINKPH Shareholding Pattern
LINKPH Shareholding Pattern
LINKPH Shareholding History
LINKPH Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing LINKPH stock
smallcases containing LINKPH stock
Looks like this stock is not in any smallcase yet.
LINKPH Events
LINKPH Events
LINKPH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
LINKPH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
LINKPH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
LINKPH has not given any dividends in last 5 years
LINKPH Dividends
LINKPH Dividends
Hmm, looks like data is unavailable here. Please come back after some timeLINKPH Stock News & Opinions
LINKPH Stock News & Opinions
Articles & Videos
Corporate
Corporate
Link Pharma Chem re-appoints Rishikesh Thakur as Managing Director for three yearsLink Pharma Chem Limited announced the re-appointment of Mr. Rishikesh Thakur as Managing Director for a period of three years, effective September 24, 2026, as approved at the company's Annual General Meeting held on August 20, 2026. Mr. Thakur, whose Director Identification Number is 08777265, holds a degree in Polymer Engineering from London Metropolitan University and is the son of Satish G. Thakur, the Chairman & Whole-time Director of Link Pharma Chem Limited.
2 weeks agoCapital Market - Live
Corporate
Corporate
Link Pharma Chem re-appoints Satish G. Thakur as Chairman for three yearsLink Pharma Chem Limited announced the re-appointment of Mr. Satish G. Thakur as Chairman and Whole-time Director for a period of three years, effective June 24, 2026, as approved at the company's Annual General Meeting held on August 20, 2026. Mr. Thakur, who has been associated with the company since its incorporation, holds a degree in B.Sc., L.Tech and has over 43 years of experience in the industry, and is the father of Mr. Rishikesh Thakur, the Managing Director of Link Pharma Chem Limited.
2 weeks agoCapital Market - Live
Corporate
Corporate
Link Pharma Chem to convene board meetingLink Pharma Chem will hold a meeting of the Board of Directors of the Company on 5 August 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Link Pharma Chem to hold AGMLink Pharma Chem announced that the Annual General Meeting(AGM) of the company will be held on 20 August 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Link Pharma Chem reports standalone net loss of Rs 0.41 crore in the March 2026 quarterNet Loss of Link Pharma Chem reported to Rs 0.41 crore in the quarter ended March 2026 as against net loss of Rs 0.35 crore during the previous quarter ended March 2025. Sales rose 2.17% to Rs 6.59 crore in the quarter ended March 2026 as against Rs 6.45 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 0.08 crore in the year ended March 2026 as against net loss of Rs 1.03 crore during the previous year ended March 2025. Sales rose 7.86% to Rs 27.43 crore in the year ended March 2026 as against Rs 25.43 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.596.45 2 27.4325.43 8 OPM %-3.64-3.41 -5.290.51 - PBDT-0.24-0.24 0 1.12-0.46 LP PBT-0.49-0.48 -2 0.14-1.40 LP NP-0.41-0.35 -17 0.08-1.03 LP Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Link Pharma Chem announces board meeting dateLink Pharma Chem will hold a meeting of the Board of Directors of the Company on 21 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Link Pharma Chem reports standalone net profit of Rs 0.07 crore in the December 2025 quarterNet profit of Link Pharma Chem reported to Rs 0.07 crore in the quarter ended December 2025 as against net loss of Rs 0.67 crore during the previous quarter ended December 2024. Sales rose 26.03% to Rs 6.73 crore in the quarter ended December 2025 as against Rs 5.34 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales6.735.34 26 OPM %10.402.25 - PBDT0.36-0.65 LP PBT0.11-0.89 LP NP0.07-0.67 LP Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Link Pharma Chem to announce Quarterly ResultLink Pharma Chem will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Link Pharma Chem reports standalone net profit of Rs 0.02 crore in the September 2025 quarterNet profit of Link Pharma Chem reported to Rs 0.02 crore in the quarter ended September 2025 as against net loss of Rs 0.31 crore during the previous quarter ended September 2024. Sales rose 31.04% to Rs 6.29 crore in the quarter ended September 2025 as against Rs 4.80 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales6.294.80 31 OPM %5.56-6.25 - PBDT0.27-0.15 LP PBT0.02-0.39 LP NP0.02-0.31 LP Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Link Pharma Chem to conduct board meetingLink Pharma Chem will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -4.53%, vs industry avg of 14.14%
Over the last 5 years, market share decreased from 0.04% to 0.02%
Over the last 5 years, net income has grown at a yearly rate of -44.11%, vs industry avg of 10.08%